Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid.

× No keyword cloud information.

21 in total

Review 1. National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons.

Authors: Neil Majithia; Sarah M Temkin; Kathryn J Ruddy; Andreas S Beutler; Dawn L Hershman; Charles L Loprinzi
Journal: Support Care Cancer Date: 2015-12-19 Impact factor: 3.603

2. Low-level laser therapy alleviates mechanical and cold allodynia induced by oxaliplatin administration in rats.

Authors: Y-L Hsieh; Y-C Fan; C-C Yang
Journal: Support Care Cancer Date: 2015-05-26 Impact factor: 3.603

Review 3. Mitotoxicity in distal symmetrical sensory peripheral neuropathies.

Authors: Gary J Bennett; Timothy Doyle; Daniela Salvemini
Journal: Nat Rev Neurol Date: 2014-05-20 Impact factor: 42.937

Review 4. Therapeutic strategies for cancer treatment related peripheral neuropathies.

Authors: Deirdre R Pachman; James C Watson; Charles L Loprinzi
Journal: Curr Treat Options Oncol Date: 2014-12

5. Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study.

Authors: Stefan von Delius; Florian Eckel; Stefan Wagenpfeil; Martina Mayr; Konrad Stock; Frank Kullmann; Florian Obermeier; Johannes Erdmann; Renate Schmelz; Stefan Quasthoff; Helmuth Adelsberger; Rainer Bredenkamp; Roland M Schmid; Christian Lersch
Journal: Invest New Drugs Date: 2006-09-13 Impact factor: 3.850

6. Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial.

Authors: Ying Guo; Desiree Jones; J Lynn Palmer; Arthur Forman; Shaker R Dakhil; Maria R Velasco; Matthias Weiss; Paul Gilman; G M Mills; Stephen J Noga; Cathy Eng; Michael J Overman; Michael J Fisch
Journal: Support Care Cancer Date: 2013-12-22 Impact factor: 3.603

7. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).

Authors: Janet M Schloss; Maree Colosimo; Caroline Airey; Paul Masci; Anthony W Linnane; Luis Vitetta
Journal: Support Care Cancer Date: 2016-09-09 Impact factor: 3.603

Review 8. The challenges of colorectal cancer survivorship.

Authors: Crystal S Denlinger; Andrea M Barsevick
Journal: J Natl Compr Canc Netw Date: 2009-09 Impact factor: 11.908

9. Oral Calcium Ameliorating Oxaliplatin-Induced Peripheral Neuropathy.

Authors: Muhammad Wasif Saif
Journal: J Appl Res Date: 2004-01-01

10. A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors.

Authors: Jennifer S Gewandter; Supriya G Mohile; Charles E Heckler; Julie L Ryan; Jeffrey J Kirshner; Patrick J Flynn; Judith O Hopkins; Gary R Morrow
Journal: Support Care Cancer Date: 2014-02-16 Impact factor: 3.603